What's New

Last Posted: Mar 14, 2023

• Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
  Shaoxu Wu et al. The Lancet. Oncology 2023
• A Favorable Benefit-Risk Balance Maybe Expected with the Replication-defective Adenovirus-mediated Interferon Gene Therapy for Cancer Treatment.
  Albert Qin et al. Human gene therapy 2023
• Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.
  Abrar Mian et al. BJUI compass 2023 4(2) 156-163
• Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis.
  Nassour Anthony-Joe et al. Cancers 2023 15(2)
• Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence.
  Moore Nicholas S et al. Seminars in radiation oncology 2022 33(1) 70-75
• A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy.
  Guo Yupeng et al. Aging 2022 14
• TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region.
  Pakmanesh Hamid et al. International journal of molecular sciences 2022 23(22)
• Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes.
  Li Lianjun et al. Aging 2022 14
• Genitourinary manifestations of Lynch syndrome in the urological practice.
  Lonati Chiara et al. Asian journal of urology 2022 9(4) 443-450
• Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men.
  Teleka Stanley et al. Scientific reports 2022 12(1) 18336
• Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population.
  Wu Peihong et al. BioMed research international 2022 20222988159
• Landscape of RB1 alterations in 22,432 Chinese solid tumor patients.
  Xu Guanghui et al. Annals of translational medicine 2022 10(16) 885
• Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer.
  Gresser Eva et al. European urology focus 2022
• Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations.
  Kurzrock Razelle et al. Cancers 2022 14(17)
• Competitive Risk Model for Specific Mortality Prediction in Patients with Bladder Cancer: A Population-Based Cohort Study with Machine Learning.
  Su Hao et al. Journal of oncology 2022 20229577904
• Uncovering additional predictors of urothelial carcinoma from voided urothelial cell clusters through a deep learning-based image preprocessing technique.
  Levy Joshua J et al. Cancer cytopathology 2022
• Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
  Ahmed Mohamed E et al. European urology focus 2022
• Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
  Pietzak Eugene J et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022
• Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.
  Yap Timothy A et al. JAMA network open 2022 5(5) e2213070
• Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
  Zeng Chenjie et al. JAMA oncology 2022

More